InflaRx NV (IFRX)
1.56
+0.03
(+1.96%)
USD |
NASDAQ |
Oct 23, 16:00
1.57
+0.01
(+0.64%)
After-Hours: 20:00
InflaRx Price : 1.56 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.51 | 1.585 | 1.48 | 1.56 | 889583.0 |
| Oct 22, 2026 | 1.55 | 1.60 | 1.51 | 1.53 | 404205.0 |
| Oct 21, 2026 | 1.55 | 1.61 | 1.54 | 1.55 | 701424.0 |
| Oct 20, 2026 | 1.45 | 1.61 | 1.44 | 1.54 | 724082.0 |
| Oct 19, 2026 | 1.33 | 1.48 | 1.285 | 1.45 | 2.806M |
| Oct 16, 2026 | 1.47 | 1.475 | 1.29 | 1.32 | 1.535M |
| Oct 15, 2026 | 1.47 | 1.53 | 1.43 | 1.44 | 552043.0 |
| Oct 14, 2026 | 1.53 | 1.536 | 1.46 | 1.48 | 585673.0 |
| Oct 13, 2026 | 1.59 | 1.605 | 1.54 | 1.55 | 367525.0 |
| Oct 12, 2026 | 1.60 | 1.64 | 1.545 | 1.59 | 467927.0 |
| Oct 09, 2026 | 1.55 | 1.695 | 1.546 | 1.60 | 740709.0 |
| Oct 08, 2026 | 1.55 | 1.60 | 1.47 | 1.53 | 1.142M |
| Oct 07, 2026 | 1.60 | 1.60 | 1.55 | 1.56 | 460353.0 |
| Oct 06, 2026 | 1.69 | 1.78 | 1.565 | 1.58 | 720672.0 |
| Oct 05, 2026 | 1.70 | 1.72 | 1.65 | 1.68 | 701008.0 |
| Oct 02, 2026 | 1.74 | 1.80 | 1.72 | 1.72 | 422162.0 |
| Oct 01, 2026 | 1.83 | 1.856 | 1.71 | 1.71 | 369956.0 |
| Sep 30, 2026 | 1.87 | 1.89 | 1.80 | 1.80 | 302499.0 |
| Sep 29, 2026 | 1.83 | 1.89 | 1.80 | 1.85 | 268405.0 |
| Sep 28, 2026 | 1.88 | 1.954 | 1.80 | 1.82 | 426389.0 |
| Sep 25, 2026 | 1.94 | 2.04 | 1.87 | 1.89 | 399902.0 |
| Sep 24, 2026 | 1.97 | 2.02 | 1.89 | 1.93 | 510186.0 |
| Sep 23, 2026 | 2.08 | 2.09 | 1.96 | 1.96 | 564758.0 |
| Sep 22, 2026 | 2.12 | 2.19 | 2.041 | 2.08 | 571272.0 |
| Sep 21, 2026 | 2.11 | 2.19 | 2.065 | 2.12 | 345150.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| MediGene AG | 0.10 |
| BioNTech SE | 88.12 |
| Immatics NV | 7.31 |
| Arrowhead Pharmaceuticals, Inc. | 58.02 |
| Oncolytics Biotech, Inc. | 0.5023 |
Price Related Metrics
| PS Ratio | 1750.70 |
| Price to Book Value | 1.376 |
| Earnings Yield | -41.56% |
| Market Cap | 229.89M |